When the new editorial team assumed their role, a number of significant changes were made to enhance our journal, Innovations. One of these changes makes its debut in this issue. The field of minimally invasive cardiothoracic and vascular surgery has progressed during the past decade both due to the innovation and technical skill of our surgical community and a similar commitment and investment from our industry partners. From its earliest days, our Society has benefitted and thrived due to this close relationship and partnership with industry. New technology is the life blood of innovation, and as surgeons, we are dependent on industry to bring our ideas and innovations to market.
Before new technology is introduced, it is imperative that surgeons develop a detailed knowledge of its strengths and limitations. To provide our readers with more detailed information regarding the technology we use everyday in the operating room and in the clinics, we are initiating a series of articles from experts in industry. These contributions will be highlighted under our “Industry Corner” Section. These articles have been solicited by the Editorial Office and have been subjected to peer review. Although they are inherently biased, they provide a detailed overview of technology from the people who helped develop and perfect them.
See accompanying article on page 294
The first contribution is from David Francischelli, Atrial Fibrillation Research Director, Structural Heart Business of Medtronic. He has been instrumental in the development of irrigated radiofrequency ablation and has spent a great deal of his professional life examining the biophysics of surgical ablation.
We hope you enjoy this initial article, and we look forward to many more in the future.
Ralph J. Damiano, Jr., MD
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery